drugset / Trial / NCT05525819
Intrathecal Versus Intravenous Dexmedetomidine in Prostate Transurethral Resection
RandomizedParallel-groupDouble-blindTreatment
Summary
This study was conducted to compare the effects of intrathecal versus intravenous dexmedetomidine administration in patients undergoing Transurethral resection of the prostate under spinal anesthesia.
Timeline
- Start
- 2022-09-01
- Primary completion
- 2023-04-29
- Completion
- 2023-04-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.4 ug/kg | Intrathecal |
| Subject | Dexmedetomidine | Other / unclassified | 5 ug | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 10 mg | Intrathecal |
Indications
No indication recorded.